13 completed, 2 terminated, 1 recruiting, 1 withdrawn. 4 Phase 2, 4 Phase 3, 4 Phase 4, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 1, Terminated 1 |
| Phase 3 | 4 | Completed 3, Terminated 1 |
| Phase 4 | 4 | Completed 3, Withdrawn 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Lundbeck LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia Vortioxetine - Fronto-temporal Dementia, Fronto-temporal Lobar Dementia | Phase 2 | Recruiting | Johns Hopkins University | 50 | 2025-03-20 | 2026-03-09 |
| Use of a Digitally Enabled App With Clinical Team Interface in the Management of Depression Pathway Platform mobile app - Major Depressive Disorder | Not applicable | Completed | Wake Forest University Health Sciences | 89 | 2021-02-19 | 2025-03-24 |
| Lundbeck TOMs Orthostatic Hypotension Droxidopa 100 MG [Northera] - Orthostatic Hypotension, Idiopathic Parkinson Disease | Phase 4 | Completed | Alberto Espay, MD, MSc | 9 | 2019-02-11 | 2022-09-26 |
| Brain Perfusion & Oxygenation in Parkinson's Disease With NOH Droxidopa, Placebo - Parkinson Disease, Neurogenic Orthostatic Hypotension | Phase 4 | Completed | William Ondo, MD | 17 | 2018-08-23 | 2022-09-06 |
| Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS) Northera (Droxidopa), Placebo - Postural Tachycardia Syndrome (POTS), Vasovagal Syncope (VVS) | Phase 2 | Terminated | New York Medical College | 30 | 2015-09-01 | 2025-05-23 |
| Clobazam Use in Epilepsia Partialis Continua - Pilot Study Clobazam, Clonazepam, Lorazepam - Epilepsia Partialis Continua, Kojewnikov's Epilepsy | Phase 3 | Terminated | The Cooper Health System | 7 | 2014-07-01 | 2018-05-09 |
| Electrical Status Epilepticus in Sleep: Response of Neuropsychological Deficits and Epileptiform Activity to Clobazam Treatment ESES treated with clobazam - Electrical Status Epilepticus in Sleep | Completed | Boston Children's Hospital | 17 | 2012-07-01 | 2015-07-30 | |
| An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms Vigabatrin - Infantile Spasms | Phase 4 | Withdrawn | Lundbeck LLC | 2012-06-01 | 2012-09-13 | |
| A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®) Sabril - Adult Refractory Complex Partial Seizures | Phase 4 | Completed | Lundbeck LLC | 65 | 2010-12-01 | 2016-06-07 |
| Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy Intravenous Carbamazepine (IV CBZ) - Epilepsy | Phase 3 | Completed | Lundbeck LLC | 108 | 2010-06-01 | 2018-01-16 |
| Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease Huntington's Disease | Completed | Ohio State University | 11 | 2010-04-01 | 2017-11-24 | |
| Sabril Patient Registry Sabril® - Infantile Spasms, Refractory Complex Partial Seizures in Adults | Completed | Lundbeck LLC | 9423 | 2009-08-01 | 2016-07-29 | |
| Clobazam in Patients With Lennox-Gastaut Syndrome Clobazam Low Dose, Clobazam Medium Dose, Clobazam High Dose - Epilepsy, Epilepsy, Generalized | Phase 3 | Completed | Lundbeck LLC | 238 | 2007-08-01 | 2012-02-09 |
| A Study of the Pharmacokinetics (PK) and Safety of IV Carbamazepine Relative to Oral Carbamazepine in Adults With Epilepsy Intravenous Carbamazepine - Epilepsy | Phase 1 | Completed | Lundbeck LLC | 98 | 2007-04-01 | 2010-04-23 |
| Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome Clobazam - Lennox-Gastaut Syndrome | Phase 3 | Completed | Lundbeck LLC | 267 | 2005-12-01 | 2018-03-21 |
| Clobazam in Subjects With Lennox-Gastaut Syndrome Clobazam Low Dose, Clobazam High Dose - Epilepsy, Epilepsy, Generalized | Phase 2 | Completed | Lundbeck LLC | 68 | 2005-10-01 | 2012-02-09 |
| Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease Melperone HCl, Placebo - Parkinson's Disease, Psychotic Disorders | Phase 2 | Completed | Lundbeck LLC | 90 | 2005-07-01 | 2011-06-17 |
Epilepsy (7) · Seizures (5) · Parkinson Disease (3) · Syncope (3) · Epilepsy, Generalized (2) · Lennox Gastaut Syndrome (2) · Spasms, Infantile (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Chorea (1) · Depressive Disorder, Major (1) · Epilepsia Partialis Continua (1) · Epilepsy, Complex Partial (1) · Epilepsy, Partial, Motor (1) · Frontotemporal Dementia (1)
Clobazam (5) · Droxidopa (3) · Vigabatrin (3) · Carbamazepine (2) · Clonazepam (1) · Lorazepam (1) · Sodium Fluoride (1) · Sugars (1) · Vortioxetine (1) · metylperon (1) · psyton (1)
United States (13) · India (2) · Australia (1) · Belarus (1) · Italy (1) · Lithuania (1)
Christopher Morrow, MD (1) · David Kemp, MD (1) · Julian M Stewart, M.D., Ph.D. (1) · Melissa Carran, MD (1) · Sandra K Kostyk, MD,PhD (1) · Tobias Loddenkemper, MD (1) · William Ondo, MD (1)
PMID 25912051, PMID 27683846, PMID 21956725, PMID 23141144, PMID 33825230, PMID 37351941, PMID 42562382
K23AG088248 (1)